1. Home
  2. AMRX vs OUT Comparison

AMRX vs OUT Comparison

Compare AMRX & OUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • OUT
  • Stock Information
  • Founded
  • AMRX 2002
  • OUT 2013
  • Country
  • AMRX United States
  • OUT United States
  • Employees
  • AMRX N/A
  • OUT N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • OUT Real Estate Investment Trusts
  • Sector
  • AMRX Health Care
  • OUT Real Estate
  • Exchange
  • AMRX Nasdaq
  • OUT Nasdaq
  • Market Cap
  • AMRX 2.5B
  • OUT 2.4B
  • IPO Year
  • AMRX N/A
  • OUT N/A
  • Fundamental
  • Price
  • AMRX $8.07
  • OUT $18.06
  • Analyst Decision
  • AMRX Strong Buy
  • OUT Buy
  • Analyst Count
  • AMRX 4
  • OUT 8
  • Target Price
  • AMRX $11.50
  • OUT $18.73
  • AVG Volume (30 Days)
  • AMRX 1.5M
  • OUT 1.4M
  • Earning Date
  • AMRX 08-05-2025
  • OUT 08-05-2025
  • Dividend Yield
  • AMRX N/A
  • OUT 6.64%
  • EPS Growth
  • AMRX N/A
  • OUT N/A
  • EPS
  • AMRX N/A
  • OUT 1.53
  • Revenue
  • AMRX $2,830,186,000.00
  • OUT $1,813,100,000.00
  • Revenue This Year
  • AMRX $9.95
  • OUT N/A
  • Revenue Next Year
  • AMRX $8.14
  • OUT $2.85
  • P/E Ratio
  • AMRX N/A
  • OUT $11.77
  • Revenue Growth
  • AMRX 13.42
  • OUT N/A
  • 52 Week Low
  • AMRX $6.50
  • OUT $12.95
  • 52 Week High
  • AMRX $9.48
  • OUT $19.98
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 49.92
  • OUT 63.56
  • Support Level
  • AMRX $7.79
  • OUT $17.64
  • Resistance Level
  • AMRX $8.48
  • OUT $18.64
  • Average True Range (ATR)
  • AMRX 0.20
  • OUT 0.44
  • MACD
  • AMRX -0.06
  • OUT 0.04
  • Stochastic Oscillator
  • AMRX 37.84
  • OUT 69.05

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About OUT OUTFRONT Media Inc.

Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's customers include entities within the retail, television, healthcare, and entertainment industries.

Share on Social Networks: